Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Select Contemporary Statistical Concepts in Heart Failure Clinical Trials: Insights From the Heart Failure Collaboratory.

JACC. Heart failure·2026
Same author

Right Ventricular Metrics as End Points in Clinical Trials: A Review.

JAMA cardiology·2026
Same author

Early effects of SGLT2 inhibitors in acute heart failure: an individual patient-level meta-analysis.

European journal of heart failure·2026
Same author

Real-time cardiac power output index predicts imminent need for extracorporeal membrane oxygenation after heart transplantation.

JHLT open·2026
Same author

Rebuilding U.S. Heart Failure Site-Based Research: A National Expert Authority Blueprint From the Heart Failure Collaboratory.

JACC. Heart failure·2026
Same author

Right Ventricular Function and Echocardiographic Characteristics After Left Atrial to Coronary Sinus Shunting; Insights from ALT-FLOW Early Feasibility Study 3 Year Follow-Up.

Journal of cardiac failure·2026

Related Experiment Video

Updated: Jun 10, 2026

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

Developing a cardiology-oncology clinical practice guideline.

Joann Lindenfeld1, Patricia A Kelly

  • 1University of Colorado Health Sciences Center, F749, Room 7083, Aurora, CO 80045, USA. joann.lindenfeld@ucdenver.edu

Progress in Cardiovascular Diseases
|August 24, 2010
PubMed
Summary

Clinical Practice Guidelines often address single diseases, but heart disease and cancer frequently coexist in elderly patients. Developing combined cardiology-oncology guidelines is crucial for managing these complex cases and improving patient outcomes.

Related Experiment Videos

Last Updated: Jun 10, 2026

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

Area of Science:

  • Cardiology
  • Oncology
  • Clinical Practice Guidelines

Background:

  • Clinical Practice Guidelines (CPGs) typically focus on single medical diagnoses.
  • Heart disease and cancer frequently coexist, particularly in elderly populations due to shared risk factors.
  • Existing CPGs offer limited guidance for patients with comorbid heart disease and cancer.

Purpose of the Study:

  • To highlight the increasing importance of managing heart disease in cancer patients.
  • To discuss the rationale, challenges, and essential steps for developing integrated cardiology-oncology guidelines.
  • To improve patient quality of life and potentially mortality by addressing cardiovascular side effects of cancer therapy.

Main Methods:

  • Discussion of the rationale for combined cardiology-oncology guidelines.
  • Identification of potential problems in developing such guidelines.
  • Outline of important steps for guideline creation.

Main Results:

  • Coexistence of heart disease and cancer necessitates integrated management strategies.
  • Cardiovascular side effects of cancer therapies are increasingly recognized.
  • Effective management of heart disease can prevent limitations on life-saving cancer treatments.

Conclusions:

  • Developing joint cardiology-oncology guidelines is essential for comprehensive patient care.
  • Addressing comorbid heart disease in cancer patients is critical for optimizing treatment outcomes and survival.
  • Integrated guidelines will enhance decision-making for practitioners and patients facing these dual diagnoses.